Mounjaro was launched in India earlier this year, while many leading multinational pharma companies are in the race to introduce Ozempic in the domestic market.

Wegovy and Mounjaro haven’t been directly compared for weight loss in clinical trials. But the weight loss effect of these drugs in people with type 2 diabetes has been compared in a review of ...

Wegovy (semaglutide) and Mounjaro (tirzepatide) are prescription drugs that may be used for weight loss and management. But only Wegovy has been FDA-approved for this use. Mounjaro is approved to ...

As India becomes the new and latest nation witnessing the for weight-loss drugs frenzy, Novo Nordisk’s Wegovy challenges Eli Lilly’s Mounjaro in a high-stakes obesity treatment challenge. While early ...

Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging ...

A recent survey highlighted a widespread lack of understanding about the much-publicised GLP-1 weight-loss medications ...

How Ozempic, Wegovy, Mounjaro, Zepbound May Help Treat Other Diseases: Here’s What To Know. ByArianna Johnson, Former Staff. Johnson is a Forbes news reporter covering health & science trends.

Marc Mckee has spoken about his experience losing nine stone in 10 months on Mounjaro, revealing the surprising psychological ...

Ozempic and Mounjaro are approved by the FDA for the treatment of type 2 diabetes, while Wegovy is approved for chronic weight management, says Aleem Kanji, M.D., a board-certified endocrinologist ...